Comparative safety and immunogenicity study of conventional subunit, MF59-adjuvanted and intradermal influenza vaccines in healthy elderly volunteers

Trial Profile

Comparative safety and immunogenicity study of conventional subunit, MF59-adjuvanted and intradermal influenza vaccines in healthy elderly volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Oct 2015

At a glance

  • Drugs Influenza virus vaccines (Primary) ; MF 59 (Primary)
  • Indications Influenza virus infections
  • Focus Adverse reactions
  • Most Recent Events

    • 15 Oct 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top